Inmune Bio, Inc. (INMB) — research page
US · us-cm-kg/NASDAQ/INMB · as of 2026-11-08
Identity and listing
The issuer is Inmune Bio, Inc., listed on NASDAQ under ticker INMB, with ISIN US45782T1051. The LEI is not on the record, as no GLEIF record carries the exact legal name in jurisdiction US-NV. The security type is Corporate, the sector is 2836 Biological Products, (No Diagnostic Substances), and the jurisdiction is United States, Nevada. The segment is not on the record. The issuer is listed and not halted.
| field | value | source · read date |
|---|---|---|
| name | Inmune Bio, Inc. | source · 2026-11-08 |
| exchange | NASDAQ | source · 2026-11-08 |
| ticker | INMB | source · 2026-11-08 |
| ISIN | US45782T1051 | source · 2026-10-05 |
| LEI | not on the record | |
| security type | Corporate | source · 2026-11-08 |
| segment | not on the record | |
| sector | 2836 Biological Products, (No Diagnostic Substances) | source · 2026-11-08 |
| jurisdiction | United States — Nevada | source · 2026-11-08 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 53 filings in the twelve months to 2026-11-08, across 34 filing days. The median gap between filing days is 7 days. The latest filing is dated 2026-11-05, is of type results, and falls 3 days before the record date. The NASDAQ median cadence gap is 6.0 days across 4359 issuers, and the NASDAQ median latency is 5.0 days. The sector median cadence gap is 5.5 days across 176 issuers, and the sector median latency is 4.0 days. The NASDAQ median filings count is 52, and the sector median filings count is 65.5. The filings by type are: corporate_news 18, directors_dealings 21, director_change 5, results 4, prospectus 2, ad_hoc 1, agm_egm 1, and regulatory_filing 1.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 53 | 7 | 3 |
| exchange median: NASDAQ (4359 issuers) | 52 | 6 | 5 |
| sector median: 2836 Biological Products, (No Diagnostic Substances) (176 issuers) | 65.5 | 5.5 | 4 |
| date | type | category | filing |
|---|---|---|---|
| 2026-11-05 | results | 10-Q | 10-Q — QUARTERLY REPORT |
| 2026-10-29 | corporate_news | 8-K | 8-K — CURRENT REPORT (items 1.01,3.02,7.01,9.01) |
| 2026-10-29 | prospectus | 424B5 | 424B5 — PROSPECTUS SUPPLEMENT |
| 2026-10-21 | corporate_news | 8-K | 8-K — CURRENT REPORT (items 7.01,8.01,9.01) |
| 2026-09-23 | directors_dealings | 4 | 4 |
window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is CBIZ CPAs P.C., located in Houston, Texas. The record holds no auditor changes.
Events and halts
The record carries one listing line, dated 2025-12-08. It carries no delisting, no name change, and no domicile change, and the domicile change is not on the record. The segment move is not on the record. The halt flag is listed, not halted.
Orderability
The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.
rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
None found. The issuer's investor-relations page names no research houses.
Open research
None found. The record holds no openly published research notes.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The issuer is sealed for the years 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.
Sources
8 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- 10.2
- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
- 10.3
- https://data.sec.gov/submissions/CIK0001711754.json (identity.jurisdiction)
- 10.4
- https://mcp.us-cm-kg.ai/events/NASDAQ/INMB (the disclosure lines)
- 10.5
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- 10.6
- https://www.sec.gov/Archives/edgar/data/1711754/000121390026036370/ea0279078-10k_inmune.htm (the auditor)
- 10.7
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.8
- https://mcp.us-cm-kg.ai/record/NASDAQ/INMB (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getissuer.ai/mcp with {"isin":"US45782T1051"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:a4d64680913808b9.